INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 46 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $163,000 | -70.2% | 211,190 | -44.0% | 0.00% | -100.0% |
| Q3 2017 | $547,000 | -51.9% | 376,951 | -10.6% | 0.00% | -50.0% |
| Q2 2017 | $1,138,000 | +2270.8% | 421,564 | +3475.9% | 0.00% | – |
| Q1 2017 | $48,000 | -92.2% | 11,789 | -92.0% | 0.00% | -100.0% |
| Q4 2016 | $616,000 | +182.6% | 146,719 | +357.1% | 0.00% | – |
| Q3 2016 | $218,000 | +31.3% | 32,100 | +12.1% | 0.00% | – |
| Q2 2016 | $166,000 | -4.0% | 28,644 | +42.5% | 0.00% | – |
| Q3 2015 | $173,000 | – | 20,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|